What Researchers Did
Researchers retrospectively examined the effectiveness of hyperbaric oxygenation (OHP) in 522 patients with sudden deafness over a ten-year period.
What They Found
Overall, 19.7% of patients achieved complete recovery, 34.9% showed definite improvement (including complete recovery), and 58.1% had slight improvement (including definite improvement). For 161 patients who had not improved after initial therapy elsewhere, HBOT administered at 2.5 atmospheres for 80 minutes daily (10-15 sessions) led to complete recovery in 13.0%, definite improvement in 19.3%, and slight improvement in 39.1%.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen therapy (HBOT) could be a beneficial treatment option for sudden deafness, potentially offering improvement even for those who haven't responded to initial treatments. Canadian patients experiencing sudden hearing loss might consider discussing HBOT with their healthcare providers as a potential part of their treatment plan.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a retrospective study, this research lacked a control group, which limits the ability to definitively attribute improvements solely to hyperbaric oxygen therapy.